Labcorp’s Dr. Rebecca Previs, an oncologist and recognized leader in the oncology diagnostics field, joined us for a live Q&A as part of our Ask the Expert webinar series. In this webinar, Dr. Previs discusses:
- Definition of HER2-low
- How HER2-low status impacts treatment options
- How personalized medicine is transforming breast cancer treatment
